Literature DB >> 26126923

Increased frequency of double and triple heterozygous gene variants in children with intrahepatic cholestasis.

Monique L Goldschmidt1,2, Reena Mourya1,2, Jessica Connor3,2, Phillip Dexheimer4,2, Rebekah Karns4,2, Alexander Miethke1,2, Rachel Sheridan5,2, Kejian Zhang3,2, Jorge A Bezerra1,2.   

Abstract

AIM: Single gene mutations cause syndromes of intrahepatic cholestasis, but previous multi-gene mutation screening in children with idiopathic cholestasis failed to fulfill diagnostic criteria in approximately two-thirds of children. In adults with fibrosing cholestatic disease, heterozygous ABCB4 mutations were present in 34% of patients. Here, we hypothesized that children with idiopathic cholestasis have a higher frequency of heterozygous non-synonymous gene sequence variants.
METHODS: We analyzed the frequency and types of variants in 717 children in whom high-throughput sequencing of the genes SERPINA1, JAG1, ATP8B1, ABCB11 and ABCB4 was performed as part of an evaluation for idiopathic intrahepatic cholestasis cholestasis. The frequency of non-synonymous variants (NSV) was compared with those of 1092 control subjects enrolled in the 1000 Genome Project.
RESULTS: The frequency of NSV in single genes was similar between disease (25%) and controls (26%, P = 0.518). In contrast, double or triple NSV in two or more genes were more frequent in disease (n = 7%) than controls (n = 4.7%, P = 0.028). Detailed review of clinical and laboratory information in a subgroup of double or triple heterozygous patients revealed variable γ-glutamyltransferase levels and severity of pruritus, with liver biopsies showing stage 2-3 fibrosis.
CONCLUSION: Children with idiopathic intrahepatic cholestasis have a higher frequency of double or triple NSV in SERPINA1, JAG1, ATPB1, ABCB11 or ABCB4. These findings raise the potential role for gene-gene relationships in determining the phenotype of cholestatic liver disease in children.
© 2015 The Japan Society of Hepatology.

Entities:  

Keywords:  children; cirrhosis; jaundice; liver; mutations

Year:  2015        PMID: 26126923      PMCID: PMC4816673          DOI: 10.1111/hepr.12545

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  17 in total

1.  Intrahepatic cholestasis: order out of chaos.

Authors:  J A Bezerra; W F Balistreri
Journal:  Gastroenterology       Date:  1999-12       Impact factor: 22.682

2.  Prediction of deleterious human alleles.

Authors:  S Sunyaev; V Ramensky; I Koch; W Lathe; A S Kondrashov; P Bork
Journal:  Hum Mol Genet       Date:  2001-03-15       Impact factor: 6.150

Review 3.  Whatever happened to "neonatal hepatitis"?

Authors:  William F Balistreri; Jorge A Bezerra
Journal:  Clin Liver Dis       Date:  2006-02       Impact factor: 6.126

4.  EASL Clinical Practice Guidelines: management of cholestatic liver diseases.

Authors: 
Journal:  J Hepatol       Date:  2009-06-06       Impact factor: 25.083

Review 5.  Update on progressive familial intrahepatic cholestasis.

Authors:  Feras T Alissa; Ronald Jaffe; Benjamin L Shneider
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-03       Impact factor: 2.839

6.  The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood.

Authors:  E Jacquemin; J M De Vree; D Cresteil; E M Sokal; E Sturm; M Dumont; G L Scheffer; M Paul; M Burdelski; P J Bosma; O Bernard; M Hadchouel; R P Elferink
Journal:  Gastroenterology       Date:  2001-05       Impact factor: 22.682

Review 7.  The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects.

Authors:  Anne Davit-Spraul; Emmanuel Gonzales; Christiane Baussan; Emmanuel Jacquemin
Journal:  Semin Liver Dis       Date:  2010-04-26       Impact factor: 6.115

8.  Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking.

Authors:  P H Dixon; N Weerasekera; K J Linton; O Donaldson; J Chambers; E Egginton; J Weaver; C Nelson-Piercy; M de Swiet; G Warnes; E Elias; C F Higgins; D G Johnston; M I McCarthy; C Williamson
Journal:  Hum Mol Genet       Date:  2000-05-01       Impact factor: 6.150

Review 9.  Interpretation and management of hepatic abnormalities in pregnancy.

Authors:  Leila Kia; Mary E Rinella
Journal:  Clin Gastroenterol Hepatol       Date:  2013-05-23       Impact factor: 11.382

10.  ABCB4 heterozygous gene mutations associated with fibrosing cholestatic liver disease in adults.

Authors:  Marianne Ziol; Véronique Barbu; Olivier Rosmorduc; Annonciade Frassati-Biaggi; Nathalie Barget; Brigitte Hermelin; Georges L Scheffer; Selma Bennouna; Jean-Claude Trinchet; Michel Beaugrand; Nathalie Ganne-Carrié
Journal:  Gastroenterology       Date:  2008-03-26       Impact factor: 22.682

View more
  4 in total

Review 1.  Recent developments in diagnostics and treatment of neonatal cholestasis.

Authors:  Amy G Feldman; Ronald J Sokol
Journal:  Semin Pediatr Surg       Date:  2020-07-23       Impact factor: 2.754

2.  Hepatic MDR3 expression impacts lipid homeostasis and susceptibility to inflammatory bile duct obstruction in neonates.

Authors:  Alexandra N Carey; Wujuan Zhang; Kenneth D R Setchell; Julia R Simmons; Tiffany Shi; Celine S Lages; Mary Mullen; Kaitlin Carroll; Rebekah Karns; Kazuhiko Bessho; Rachel Sheridan; Xueheng Zhao; Susanne N Weber; Alexander G Miethke
Journal:  Pediatr Res       Date:  2017-05-03       Impact factor: 3.756

3.  Genome-wide association studies of metabolites in Finnish men identify disease-relevant loci.

Authors:  Xianyong Yin; Lap Sum Chan; Debraj Bose; Anne U Jackson; Peter VandeHaar; Adam E Locke; Christian Fuchsberger; Heather M Stringham; Ryan Welch; Ketian Yu; Lilian Fernandes Silva; Susan K Service; Daiwei Zhang; Emily C Hector; Erica Young; Liron Ganel; Indraniel Das; Haley Abel; Michael R Erdos; Lori L Bonnycastle; Johanna Kuusisto; Nathan O Stitziel; Ira M Hall; Gregory R Wagner; Jian Kang; Jean Morrison; Charles F Burant; Francis S Collins; Samuli Ripatti; Aarno Palotie; Nelson B Freimer; Karen L Mohlke; Laura J Scott; Xiaoquan Wen; Eric B Fauman; Markku Laakso; Michael Boehnke
Journal:  Nat Commun       Date:  2022-03-28       Impact factor: 14.919

4.  Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis.

Authors:  Natalia Gomez-Ospina; Carol J Potter; Rui Xiao; Kandamurugu Manickam; Mi-Sun Kim; Kang Ho Kim; Benjamin L Shneider; Jennifer L Picarsic; Theodora A Jacobson; Jing Zhang; Weimin He; Pengfei Liu; A S Knisely; Milton J Finegold; Donna M Muzny; Eric Boerwinkle; James R Lupski; Sharon E Plon; Richard A Gibbs; Christine M Eng; Yaping Yang; Gabriel C Washington; Matthew H Porteus; William E Berquist; Neeraja Kambham; Ravinder J Singh; Fan Xia; Gregory M Enns; David D Moore
Journal:  Nat Commun       Date:  2016-02-18       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.